1. Home
  2. Labeler Index
  3. Genentech, Inc.
  4. 50242-138
  5. NDC Package Code: 50242-138-86 Actemra

NDC Package 50242-138-86 Actemra

Tocilizumab Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50242-138-86
Package Description:
1 SYRINGE, GLASS in 1 BOX / .9 mL in 1 SYRINGE, GLASS
Product Code:
50242-138
Proprietary Name:
Actemra
Non-Proprietary Name:
Tocilizumab
Substance Name:
Tocilizumab
Usage Information:
This medication is used alone or with other medications to treat moderate to severe rheumatoid arthritis in adults. It is also used to treat rheumatoid arthritis in children (such as systemic juvenile idiopathic arthritis-SJIA, polyarticular juvenile idiopathic arthritis-PJIA). It helps to reduce pain and swelling due to rheumatoid arthritis. Tocilizumab may also be used to treat a reaction (Cytokine Release Syndrome-CRS) caused by certain cancer treatments. Tocilizumab belongs to a class of drugs known as Interleukin-6 (IL-6) blockers. It works by blocking IL-6, a substance made by the body that causes swelling (inflammation).
11-Digit NDC Billing Format:
50242013886
NDC to RxNorm Crosswalk:
  • RxCUI: 1441527 - tocilizumab 162 MG in 0.9 ML Prefilled Syringe
  • RxCUI: 1441527 - 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe
  • RxCUI: 1441527 - tocilizumab 162 MG per 0.9 ML Prefilled Syringe
  • RxCUI: 1441530 - Actemra 162 MG in 0.9 ML Prefilled Syringe
  • RxCUI: 1441530 - 0.9 ML tocilizumab 180 MG/ML Prefilled Syringe [Actemra]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Genentech, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • TOCILIZUMAB 162 mg/.9mL
    • Pharmacologic Class(es):
  • Interleukin 6 Receptor Antagonists - [MoA] (Mechanism of Action)
  • Interleukin-6 Receptor Antagonist - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    Yes
    FDA Application Number:
    BLA125472
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    10-21-2013
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    50242-138-011 SYRINGE, GLASS in 1 BOX / .9 mL in 1 SYRINGE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 50242-138-86?

    The NDC Packaged Code 50242-138-86 is assigned to a package of 1 syringe, glass in 1 box / .9 ml in 1 syringe, glass of Actemra, a human prescription drug labeled by Genentech, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.

    Is NDC 50242-138 included in the NDC Directory?

    Yes, Actemra with product code 50242-138 is active and included in the NDC Directory. The product was first marketed by Genentech, Inc. on October 21, 2013 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 50242-138-86?

    The 11-digit format is 50242013886. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-250242-138-865-4-250242-0138-86